pharmaceutical investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project